Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ

Imeglimin is a new anti-diabetic drug which promotes insulin secretion from pancreatic β-cells and reduces insulin resistance in insulin target tissues. However, there have been no reports examining the possib...

Source: Cardiovascular Diabetology - March 19, 2024 Category: Cardiology Authors: Junpei Sanada, Tomohiko Kimura, Masashi Shimoda, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Yoshiro Fushimi, Yukino Katakura, Yuka Nogami, Yoshiko Shirakiya, Yuki Yamasaki, Tomoko Ikeda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku and Hideaki Kanet Tags: Research Source Type: research